Literature DB >> 8798935

Placebos in clinical practice and research.

P P De Deyn1, R D'Hooge.   

Abstract

The main current application of placebo is in clinical research. The term placebo effect refers to diverse non-specific, desired or non-desired effects of substances or procedures and interactions between patient and therapist. Unpredictability of the placebo effect necessitates placebo-controlled designs for most trials. Therapeutic and diagnostic use of placebo is ethically acceptable only in few well-defined cases. While "therapeutic" application of placebo almost invariably implies deception, this is not the case for its use in research. Conflicts may exist between the therapist's Hippocratic and scientific obligations. The authors provide examples in neuropsychiatry, illustrating that objective scientific data and well-considered guidelines may solve the ethical dilemma. Placebo control might even be considered an ethical obligation but some provisos should be kept in mind: (a) no adequate therapy for the disease should exist and/or (presumed) active therapy should have serious side-effects; (b) placebo treatment should not last too long; (c) placebo treatment should not inflict unacceptable risks, and (d) the experimental subject should be adequately informed and informed consent given.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Substances:

Year:  1996        PMID: 8798935      PMCID: PMC1376977          DOI: 10.1136/jme.22.3.140

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  27 in total

1.  NONBLIND PLACEBO TRIAL: AN EXPLORATION OF NEUROTIC PATIENTS' RESPONSES TO PLACEBO WHEN ITS INERT CONTENT IS DISCLOSED.

Authors:  L C PARK; L COVI
Journal:  Arch Gen Psychiatry       Date:  1965-04

2.  Internal mammary ligation.

Authors:  I C BRILL; W M ROSENBAUM; E E ROSENBAUM; J R FLANERY
Journal:  Northwest Med       Date:  1958-04

3.  Bilateral internal mammary artery ligation for angina pectoris; preliminary clinical considerations.

Authors:  J R KITCHELL; R P GLOVER; R H KYLE
Journal:  Am J Cardiol       Date:  1958-01       Impact factor: 2.778

4.  Does short term placebo treatment of chronic schizophrenia produce long term harm?

Authors:  D A Curson; S R Hirsch; S D Platt; R W Bamber; T R Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

Review 5.  Is there an alternative to the randomized controlled trial?

Authors:  P Leber
Journal:  Psychopharmacol Bull       Date:  1991

6.  Heterogeneity of clinical response during placebo treatment.

Authors:  F M Quitkin; J G Rabkin; J W Stewart; P J McGrath; W Harrison; D C Ross; E Tricamo; J Fleiss; J Markowitz; D F Klein
Journal:  Am J Psychiatry       Date:  1991-02       Impact factor: 18.112

Review 7.  Predictors of placebo response in depression.

Authors:  W A Brown
Journal:  Psychopharmacol Bull       Date:  1988

8.  Prognosis of epilepsy in newly referred patients: a multicenter prospective study. Collaborative Group for the Study of Epilepsy.

Authors:  E Beghi; G Tognoni
Journal:  Epilepsia       Date:  1988 May-Jun       Impact factor: 5.864

9.  The course of untreated epilepsy.

Authors:  R D Elwes; A L Johnson; E H Reynolds
Journal:  BMJ       Date:  1988-10-15

10.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.

Authors:  P B Watkins; H J Zimmerman; M J Knapp; S I Gracon; K W Lewis
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

View more
  9 in total

1.  Is it in a neonate's best interest to enter a randomised controlled trial?

Authors:  P Allmark; S Mason; A B Gill; C Megone
Journal:  J Med Ethics       Date:  2001-04       Impact factor: 2.903

2.  Placebo effect and placebos: what are we talking about? Some conceptual and historical considerations.

Authors:  Ana Macedo; Magí Farré; Josep-E Baños
Journal:  Eur J Clin Pharmacol       Date:  2003-06-27       Impact factor: 2.953

3.  The ethics of the placebo in clinical practice.

Authors:  P Lichtenberg; U Heresco-Levy; U Nitzan
Journal:  J Med Ethics       Date:  2004-12       Impact factor: 2.903

4.  Questionnaire survey on use of placebo.

Authors:  Uriel Nitzan; Pesach Lichtenberg
Journal:  BMJ       Date:  2004-09-17

5.  The ethics of prescription of placebos to patients with major depressive disorder.

Authors:  Shun-Jie Chua; Mark Pitts
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

6.  On the use of carnosine and antioxidants: A letter from Russia.

Authors:  Sergei V Jargin
Journal:  J Intercult Ethnopharmacol       Date:  2016-04-21

Review 7.  Hormesis and homeopathy: The artificial twins.

Authors:  Sergei V Jargin
Journal:  J Intercult Ethnopharmacol       Date:  2014-11-28

8.  Comment on "Use of Carnosine for Oxidative Stress Reduction in Different Pathologies".

Authors:  S V Jargin
Journal:  Oxid Med Cell Longev       Date:  2016-07-17       Impact factor: 6.543

Review 9.  Exercise-Based Muscle Development Programmes and Their Effectiveness in the Functional Recovery of Rotator Cuff Tendinopathy: A Systematic Review.

Authors:  Juan G Dominguez-Romero; José J Jiménez-Rejano; Carmen Ridao-Fernández; Gema Chamorro-Moriana
Journal:  Diagnostics (Basel)       Date:  2021-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.